About ACGcaps™ GI
Developed specifically for use with sustainable (no propellant) dry powder inhalation devices and a wide range of formulations, ACGcaps™ GI ensures accurate dosing, uniform dispersion, and efficient delivery to the respiratory system, enhancing drug effectiveness and patient outcomes.
Key features
- Low powder retention for maximum dose delivery
- Proven puncturing, cutting and twist-open performance
- Compatible with several dry powder inhalation devices
- Suitable for a wide range of active pharmaceutical ingredients
- Proven machine-friendly design
- Complies with stringent regulatory requirements for microbiological limits
Technical specifications
- Powder retention: not more than 1.0%
- Moisture content: 13.0% to 16.0%
- Microbial limit: not more than 100 CFU
Suitability
Pharmaceutical
Certifications are applicable to certain colours and/or variants.
Image
Case studies
You can’t have healthy people without a healthy planet.